Targeting TGFβR2-mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer.
Huang H, Zhang Y, Gallegos V, Sorrelle N, Zaid MM, Toombs J, Du W, Wright S, Hagopian M, Wang Z, Hosein AN, Sathe AA, Xing C, Koay EJ, Driscoll KE, Brekken RA.
Huang H, et al. Among authors: hosein an.
EMBO Mol Med. 2019 Nov 7;11(11):e10515. doi: 10.15252/emmm.201910515. Epub 2019 Oct 14.
EMBO Mol Med. 2019.
PMID: 31609088
Free PMC article.